Earnings Feed
Start Free
Home/Filings/3/0000932440-05-000063
3//SEC Filing

PROQUEST INVESTMENTS II ADVISORS FUND LP 3

Accession 0000932440-05-000063

CIK 0001183765other
View on SEC.govCompany Profile

Filed

Feb 3, 7:00 PM ET

Accepted

Feb 4, 3:47 PM ET

Size

19.5 KB

Accession

0000932440-05-000063

Insider Transaction Report

Form 3
Period: 2005-02-04
THRESHOLD PHARMACEUTICALS INCTHLD
SCHREIBER ALAIN
10% Owner
Holdings

  • Common Stock

    138,640

  • Common Stock

    3,301,565

  • Common Stock

    (indirect: By LLC)
    3,440,205
PROQUEST ASSOCIATES II LLC
10% Owner
Holdings

  • Common Stock

    3,301,565

  • Common Stock

    138,640

  • Common Stock

    (indirect: By LLC)
    3,440,205
PROQUEST INVESTMENTS II LP
10% Owner
Holdings

  • Common Stock

    3,301,565

  • Common Stock

    138,640

  • Common Stock

    (indirect: By LLC)
    3,440,205
PROQUEST INVESTMENTS II ADVISORS FUND LP
10% Owner
Holdings

  • Common Stock

    138,640

  • Common Stock

    (indirect: By LLC)
    3,440,205

  • Common Stock

    3,301,565
Moorin Jay
10% Owner
Holdings

  • Common Stock

    (indirect: By LLC)
    3,440,205

  • Common Stock

    138,640

  • Common Stock

    3,301,565
Footnotes (4)
  • [F1]This line of Form 3 reports the direct beneficial ownership of shares of Threshold Pharmaceuticals, Inc. ("Threshold") by ProQuest Investments II, L.P., a Delaware limited partnership ("Investments II").
  • [F2]This line of Form 3 reports the direct beneficial ownership of shares of Threshold by ProQuest Investments II Advisors Fund,L.P., a Delware limited partnership ("Advisors").
  • [F3]This line of Form 3 reports the indirect beneficial ownership of shares of Threshold by ProQuest Associates II LLC ("Associates"), as the general partner of each of Investments II and Advisors, and by Jay Moorin and Alain Schreiber, as managing members of Associates.
  • [F4]The filing of this Form 3 shall not be deemed an admission that the Reporting Persons are or were, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the beneficial owners of any securities covered by this Form. Each of the Reporting Persons disclaims beneficial ownership in the securities covered by this Form except to the extent such Reporting Persons' pecuniary interest in such securities.

Documents

4 files

Issuer

THRESHOLD PHARMACEUTICALS INC

CIK 0001183765

→
Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001143319

Filing Metadata

Form type
3
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 3:47 PM ET
Size
19.5 KB
View on SEC.gov